Drugs / 35 kDa hyaluronan fragment
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06387212 | Apr → May 2024 | dermatitis | Nakhia Impex LLC | Unknown | No outcome recorded |
| — | NCT05812300 | Jun 2023 → Jan 2024 | periodontitis | Dove Medical Press Ltd | Completed | No outcome recorded |
| — | NCT05852002 | Apr → Nov 2023 | lung cancer | Nakhia Impex LLC | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 35 kDa hyaluronan fragment | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06387212 ↗ |
| Known as | HA35 | “35 kDa hyaluronan fragment HA35 injection” NCT06387212 ↗ |
| Route | Other | “intrapocket injection” NCT05812300 ↗ |